Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Intel (NASDAQ:INTC) Shares Rise on AI Trends and New Processor Launch

Shares of Intel Corp (NASDAQ:INTC) rose 3.41% on 21 Jan, closing at USD 48.56. The stock has shown strong gains over multiple periods, rising 33.52% over the past month, 108.77% over the past six months, and 123.06% over the past year. Analysts have highlighted …

Team Kalkine | 21 January 2026

Oklo (NYSE:OKLO) Shares Slide 5% Amid Tariff Concerns

Shares of Oklo Inc. (NYSE:OKLO) moved lower on Tuesday, closing the session down 5.3% at USD 89.93, as U.S. equity markets recorded their weakest performance in several months. The decline came as both the S&P 500 and the Nasdaq Composite fell sharply, dropping 2.1% …

Team Kalkine | 21 January 2026

What Triggered Target Price Cuts for MiMedx (NASDAQ:MDXG) and Crown Castle (NYSE: CCI)?

Recent target price reductions for MiMedx Group and Crown Castle were driven by analyst reassessments following quarterly earnings releases and forward-looking assumptions. Although both companies reported earnings per share above consensus expectations, research firms adjusted valuation models to reflect updated revenue trends, margin considerations, …

Team Kalkine | 21 January 2026

AlphaTON Capital (NASDAQ:ATON) to Launch Privacy-Preserving AI Agents on Telegram

AlphaTON Capital Corp (NASDAQ:ATON) announced a definitive agreement with the Midnight Foundation to integrate privacy-preserving AI agents within Telegram, which has an addressable market of one billion monthly active users. The collaboration combines AlphaTON’s Cocoon AI infrastructure with Midnight’s zero-knowledge blockchain to enable fully …

Team Kalkine | 20 January 2026

ImmunityBio (NASDAQ: IBRX) Shares Surge on ANKTIVA® sBLA FDA Updates

ImmunityBio, Inc. (NASDAQ:IBRX) recently conducted a Type B End-of-Phase meeting with the U.S. FDA regarding its supplemental Biologics License Application (sBLA) for ANKTIVA® (nogapendekin alfa inbakicept) plus Bacillus Calmette-Guérin (BCG). The application focuses on patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) presenting with …

Team Kalkine | 20 January 2026

What Recent Payout Updates Mean for AMGN, EPD, and HTCR?

Dividend announcements remain a key reference point for investors tracking income-related corporate actions across USequitymarkets. Amgen Inc, Enterprise Products Partners, and HeartCore Enterprises each reporteddividendor distribution-related updates tied to their recent financial disclosures. These actions reflect differentcapitalreturn structures across biotechnology, midstream energy, and advisory …

Team Kalkine | 19 January 2026

Is NATO’s Unity Under Pressure Amid Greenland Dispute?

President Donald Trump has pushed the North Atlantic Treaty Organization into one of the most severe crises in its history after threatening tariffs against NATO allies opposing US control of Greenland. The move has intensified concerns that the alliance’s core principle of collective defense …

Team Kalkine | 19 January 2026

What’s Driving Lithium Americas (NYSE:LAR) Stock Following a 51% Rise in One Month

Lithium Americas Corp. (NYSE:LAR) is currently rated Buy on a consensus basis, according to EODHD/Others data, with an average analyst score of 2.13. Analysts have set an average target price of USD 6.79, which suggests a potential downside of roughly 17.1% from recent trading …

Team Kalkine | 19 January 2026

Mosaic (NYSE: MOS) Slides Over 4% on Analyst Downgrade Following Preliminary Results

Shares of Mosaic Co. (NYSE:MOS) ended the week under pressure, falling by more than 4% on Friday after an analyst lowered her recommendation on the agricultural products company. The stock reaction came one day after Mosaic released its preliminary fourth-quarter results, which prompted reassessment …

Team Kalkine | 19 January 2026

Earnings Beats, Softer Outlooks: Why Wall Street Hit “Pause” on These Stocks

Wall Street’s recent reassessment of several stocks has brought renewed attention to short-term price movements, particularly for companies shifted to a “Hold” rating. Makita Corporation, Prelude Therapeutics, and Docebo all saw rating downgrades from Wall Street Zen, placing their recent trading performance under the …

Team Kalkine | 19 January 2026